Gene Therapy Types - Global
GT.13 Oncolytic Virus Therapy
Gene Therapy classification code GT.13 covers "Oncolytic Virus Therapy" at level 2 of the Gene Therapy hierarchy.
Level 2
Is your business really a GT.13?Classify itWhere GT.13 sits in the Gene Therapy hierarchy
- >GT Gene Therapy Types
- >>GT.13 Oncolytic Virus Therapy
- >>GT.13 Oncolytic Virus Therapy
Other Gene Therapy codes under GT.13 Oncolytic Virus Therapy
- GT.01In Vivo Gene Therapy
- GT.02Ex Vivo Gene Therapy
- GT.03AAV Vector Therapy
- GT.04Lentiviral Vector Therapy
- GT.05Retroviral Vector Therapy
- GT.06mRNA Therapy
- GT.07CRISPR Gene Editing
- GT.08Antisense Oligonucleotide
- GT.09siRNA Therapy
- GT.10Gene Augmentation
- GT.11Gene Silencing
- GT.12Gene Replacement
- GT.14Base Editing
Frequently asked questions
- What is Gene Therapy GT.13?
- Gene Therapy GT.13 is "Oncolytic Virus Therapy". Gene Therapy code GT.13 covers "Oncolytic Virus Therapy" at level 2 of the Gene Therapy hierarchy.
- What is the parent category of GT.13?
- GT.13 Oncolytic Virus Therapy sits under GT.13 Oncolytic Virus Therapy in the Gene Therapy hierarchy.
Classify my business
Describe your business in plain English and get matching codes across Gene Therapy and other major systems.
Interactive browser
Open GT.13 in the full interactive explorer with tree view, search, and drill-downs.